Literature DB >> 24468043

Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration.

Saher S Sabri1, Nadine Abi-Jaoudeh2, Warren Swee3, Wael E Saad4, Ulku C Turba4, Stephen H Caldwell5, John F Angle4, Alan H Matsumoto4.   

Abstract

PURPOSE: To assess the short-term rebleeding rate associated with the use of a transjugular intrahepatic portosystemic shunt (TIPS) compared with balloon-occluded retrograde transvenous obliteration (BRTO) for management of gastric varices (GV).
MATERIALS AND METHODS: A single-center retrospective comparison of 50 patients with bleeding from GV treated with a TIPS or BRTO was performed. Of 50 patients, 27 (17 men and 10 women; median age, 55 y; range, 31-79 y) received a TIPS with covered stents, and 23 (12 men and 11 women; median age, 52 y; range, 23-83 y) underwent a BRTO procedure with a foam sclerosant. All study subjects had clinical and endoscopic evidence of isolated bleeding GV and were hemodynamically stable at the time of the procedure. Clinical and endoscopic follow-up was performed. Kaplan-Meier analysis was used to evaluate rebleeding rates from the GV.
RESULTS: The technical success rate was 100% in the TIPS group and 91% in the BRTO group (P = .21). Major complications occurred in 4% of the patients receiving TIPS and 9% of patients the undergoing BRTO (P = .344). Encephalopathy was reported in 4 of 27 (15%) patients in the TIPS group and in none of the patients in the BRTO group (0%; P = .12). At 12 months, the incidence of rebleeding from a GV source was 11% in the TIPS group and 0% in the BRTO group (P = .25).
CONCLUSIONS: BRTO appears to be equivalent to TIPS in the short-term for management of bleeding GV. Further comparative studies are warranted to determine optimal management strategies in individual patients.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24468043     DOI: 10.1016/j.jvir.2013.12.001

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  15 in total

Review 1.  Combining Transjugular Intrahepatic Portosystemic Shunt with Balloon-Occluded Retrograde Transvenous Obliteration or Augmenting TIPS with Variceal Embolization for the Management of Gastric Varices: An Evolving Middle Ground?

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

2.  Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices.

Authors:  Nobuo Waguri; Akihiko Osaki; Shunzo Ikarashi; Masahiro Ogawa; Naosuke Kuraoka; Kohei Ogawa; Munehiro Sato; Tsuneo Aiba; Osamu Yoneyama; Koichi Furukawa; Kazuhito Sugimura; Kentarou Igarashi
Journal:  United European Gastroenterol J       Date:  2015-04-09       Impact factor: 4.623

Review 3.  An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.

Authors:  Seung Kwon Kim; Bryan G Belikoff; Carlos J Guevara; Seong Jin Park
Journal:  Dig Dis Sci       Date:  2017-01-05       Impact factor: 3.199

Review 4.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

5.  Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt.

Authors:  Qin Jiang; Ming-Quan Wang; Guo-Bing Zhang; Qiong Wu; Jian-Ming Xu; De-Run Kong
Journal:  World J Hepatol       Date:  2016-07-18

6.  U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.

Authors:  Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; David Patch; Charles Millson; Homoyon Mehrzad; Andrew Austin; James W Ferguson; Simon P Olliff; Mark Hudson; John M Christie
Journal:  Gut       Date:  2015-04-17       Impact factor: 23.059

7.  Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Fuliang He; Shan Dai; Zhibo Xiao; Lei Wang; Zhendong Yue; Hongwei Zhao; Mengfei Zhao; Qiushi Lin; Xiaoqun Dong; Fuquan Liu
Journal:  Biomed Res Int       Date:  2016-11-15       Impact factor: 3.411

8.  Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.

Authors:  Seung Kwon Kim; Kristen A Lee; Steven Sauk; Kevin Korenblat
Journal:  Korean J Radiol       Date:  2017-02-07       Impact factor: 3.500

Review 9.  Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

Authors:  Olivier Chevallier; Kévin Guillen; Pierre-Olivier Comby; Thomas Mouillot; Nicolas Falvo; Marc Bardou; Marco Midulla; Ludwig-Serge Aho-Glélé; Romaric Loffroy
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

10.  Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Authors:  Thomas Reiberger; Andreas Püspök; Maria Schoder; Franziska Baumann-Durchschein; Theresa Bucsics; Christian Datz; Werner Dolak; Arnulf Ferlitsch; Armin Finkenstedt; Ivo Graziadei; Stephanie Hametner; Franz Karnel; Elisabeth Krones; Andreas Maieron; Mattias Mandorfer; Markus Peck-Radosavljevic; Florian Rainer; Philipp Schwabl; Vanessa Stadlbauer; Rudolf Stauber; Herbert Tilg; Michael Trauner; Heinz Zoller; Rainer Schöfl; Peter Fickert
Journal:  Wien Klin Wochenschr       Date:  2017-10-23       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.